certify
|

Anca Spanu Anca's career in journalism spans over 2 decades. She has served as staff writer, editor and deputy chief editor at various media outlets all over the world. At Healthcare Weekly, Anca writes about current events, innovations in the healthcare space and events/ conferences with a focus on investing & startups.

Arvinas goes public to bring its PROTAC-based anticancer drug to the market looking at an $100 mn IPO
Biotech Pharma
Arvinas goes public to bring its PROTAC-based anticancer drug to the market looking at an $100 mn IPO
September 1, 2018 6696 Views
On August 30th Arvinas, a preclinical biotech that is developing protein therapies for metastatic cancers, filed with the ...
Read more    
banner
Adsense
Healthcare Weekly

SOCIAL MEDIA


Contact Us Advertising / Sponsorships
© Copyright 2024 Healthcare Weekly.
Privacy Policy | Terms of Service | Cookie Policy
[email protected]
Healthcare Weekly
© Copyright 2024 Healthcare Weekly